Press Releases

Principio, Inc. Announces Licensing Agreement for Novel
Molecular Imaging and Therapeutic Radiopharmaceuticals for theTreatment of Cancer with Johns Hopkins School of Medicine

ROCKVILLE, MD, Feb. 10, 2010 — Principio Inc., a privately held emerging company developing novel molecular imaging agents and therapeutic radiopharmaceuticals for the treatment of cancer, today announced that the Company has obtained an exclusive license to several technologies developed at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center. View PDF

Principio
15601 Crabbs Branch Way
Rockville, MD 20855
USA

301.526.5197 (phone)
301.738.0779 (fax)
info@principioinc.com